Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

BACKGROUND: We aimed to examine whether patients with de novo and relapsed/progressed stage IIIB–IV non-small cell lung cancer (NSCLC) without epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutations have different prognoses. METHODS: This retrospective study analyzed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Byeong-Chan, Cho, Ae-Ryeo, Nam, Jin Hyun, Yang, So-Young, Kim, Min Ji, Kwon, Sun-Hong, Lee, Eui-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226257/
https://www.ncbi.nlm.nih.gov/pubmed/37248452
http://dx.doi.org/10.1186/s12885-023-10950-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226257/
https://www.ncbi.nlm.nih.gov/pubmed/37248452
http://dx.doi.org/10.1186/s12885-023-10950-y

Ejemplares similares